verapamil hydrochloride

Generic: verapamil hydrochloride

Labeler: mylan institutional inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name verapamil hydrochloride
Generic Name verapamil hydrochloride
Labeler mylan institutional inc.
Dosage Form CAPSULE, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

verapamil hydrochloride 120 mg/1

Manufacturer
Mylan Institutional Inc.

Identifiers & Regulatory

Product NDC 51079-917
Product ID 51079-917_3a87770c-fa53-d061-e063-6294a90a6751
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA075138
Listing Expiration 2026-12-31
Marketing Start 1999-10-01

Pharmacologic Class

Classes
calcium channel antagonists [moa] calcium channel blocker [epc] cytochrome p450 3a inhibitors [moa] cytochrome p450 3a4 inhibitors [moa] p-glycoprotein inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 51079917
Hyphenated Format 51079-917

Supplemental Identifiers

RxCUI
897612
UNII
V3888OEY5R

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name verapamil hydrochloride (source: ndc)
Generic Name verapamil hydrochloride (source: ndc)
Application Number ANDA075138 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 120 mg/1
source: ndc
Packaging
  • 100 BLISTER PACK in 1 CARTON (51079-917-20) / 1 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (51079-917-01)
source: ndc

Packages (1)

51079-917-20 100 BLISTER PACK in 1 CARTON (51079-917-20) / 1 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (51079-917-01)

Ingredients (1)

verapamil hydrochloride (120 mg/1)

Linked Drug Pages (1)

Verapamil Hydrochloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "3a87770c-fa53-d061-e063-6294a90a6751", "openfda": {"unii": ["V3888OEY5R"], "rxcui": ["897612"], "spl_set_id": ["3bee2d26-138c-4641-a217-a38d3d657461"], "manufacturer_name": ["Mylan Institutional Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 BLISTER PACK in 1 CARTON (51079-917-20)  / 1 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (51079-917-01)", "package_ndc": "51079-917-20", "marketing_start_date": "19991001"}], "brand_name": "Verapamil Hydrochloride", "product_id": "51079-917_3a87770c-fa53-d061-e063-6294a90a6751", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "51079-917", "generic_name": "verapamil hydrochloride", "labeler_name": "Mylan Institutional Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Verapamil Hydrochloride", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "120 mg/1"}], "application_number": "ANDA075138", "marketing_category": "ANDA", "marketing_start_date": "19991001", "listing_expiration_date": "20261231"}